Business Description
Medinotec Inc
NAICS : 423450
SIC : 5047
ISIN : US58500G1076
Share Class Description:
MDNC: Ordinary SharesTotal Employee Number:
48Description
Medinotec Inc is a medical device manufacturing and distribution company engaged in tracheal non-occlusive airway dilation technology and medical device design. It generates revenue from two sources: internally designed and manufactured medical devices and distribution of third-party medical products under exclusive or non-exclusive agreements in defined territories. Its products include the Trachealator, the Outflo Aortic Valve Dilation Balloon Catheter, and the Cape Cross family of PTCA balloon catheters. It also distributes a range of cardiology and renal dialysis products on behalf of multinational manufacturers, mainly in South Africa. Its segments are Inside the United States and Outside the United States, with Outside the United States generating maximum revenue.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 172.31 | |||||
Equity-to-Asset | 0.84 | |||||
Debt-to-EBITDA | 0.01 | |||||
Interest Coverage | 12.59 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 35.22 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 113.6 | |||||
3-Year Book Growth Rate | 30.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.83 | |||||
Quick Ratio | 4.71 | |||||
Cash Ratio | 2.5 | |||||
Days Inventory | 85.03 | |||||
Days Sales Outstanding | 102.69 | |||||
Days Payable | 93.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 1.53 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 52.71 | |||||
Operating Margin % | 11.26 | |||||
Net Margin % | 8.17 | |||||
EBITDA Margin % | 12.72 | |||||
FCF Margin % | 9.32 | |||||
OCF Margin % | 9.32 | |||||
ROE % | 16.1 | |||||
ROA % | 11.61 | |||||
ROIC % | 28.67 | |||||
3-Year ROIIC % | 74.64 | |||||
ROC (Joel Greenblatt) % | 41.45 | |||||
ROCE % | 21.69 | |||||
Years of Profitability over Past 10-Year | 2 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 71.43 | |||||
PE Ratio without NRI | 71.43 | |||||
PS Ratio | 6 | |||||
PB Ratio | 10.29 | |||||
Price-to-Tangible-Book | 10.2 | |||||
Price-to-Free-Cash-Flow | 70.42 | |||||
Price-to-Operating-Cash-Flow | 70.42 | |||||
EV-to-EBIT | 49.16 | |||||
EV-to-EBITDA | 45.98 | |||||
EV-to-Revenue | 5.85 | |||||
EV-to-FCF | 62.71 | |||||
Price-to-Graham-Number | 5.75 | |||||
| Price-to-Net-Current-Asset-Value | 11.11 | |||||
| Price-to-Net-Cash | 35.71 | |||||
Earnings Yield (Greenblatt) % | 2.03 | |||||
FCF Yield % | 1.55 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MDNC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medinotec Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 9.729 | ||
| EPS (TTM) ($) | 0.07 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | - | ||
| 20-Day SMA ($) | 5 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 5 - 5 | ||
| Shares Outstanding (Mil) | 11.76 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medinotec Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medinotec Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2027 | 2026-10-08 | In 98 days | ||
| First quarter earnings results for 2027 | 2026-07-16 | In 14 days | ||
| Annual report for 2026 | 2026-05-28 | 5.00 (+0.00%) | ||
| General meeting for 2025 | 2026-01-20 09:30 | 5.00 (+0.00%) | ||
| Third quarter earnings results for 2026 | 2026-01-09 | 5.00 (+0.00%) | ||
| Second quarter earnings results for 2026 | 2025-10-08 | 5.00 (+0.00%) | ||
| First quarter earnings results for 2026 | 2025-07-16 | 5.00 (+0.00%) | ||
| Annual report for 2025 | 2025-05-29 | 5.00 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-01-14 | 5.00 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2024-10-15 | 5.00 (+0.00%) |
Show
Entries
Medinotec Inc Frequently Asked Questions
What is Medinotec Inc(MDNC)'s stock price today?
The current price of MDNC is $5.00. The 52 week high of MDNC is $5.00 and 52 week low is $5.00.
When is next earnings date of Medinotec Inc(MDNC)?
The next earnings date of Medinotec Inc(MDNC) is 2026-07-16 Est..
Does Medinotec Inc(MDNC) pay dividends? If so, how much?
Medinotec Inc(MDNC) does not pay dividend.
Guru Commentaries on OTCPK:MDNC
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Medinotec Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers